Advanced and personalized treatments have developed over the past 10 years while incorporating cutting-edge medication delivery methods. Exosomes are naturally occurring transporters of useful short RNAs and proteins, and they are attracting growing attention in the realm of drug delivery. Exosomes are employed as carriers for the therapeutic transport of RNAs and proteins to recipient cells through their luminal content. Additionally, modified exosomes offer a benefit for the targeted distribution of medications, increasing efficacy and reducing side effects. They are promoting biomarkers in ophthalmic drug delivery. Exosomes loaded with therapeutic compounds have been utilized in ophthalmic therapy for several ocular disorders, including age-related macular disease, glaucoma, infectious endophthalmitis, diabetic retinopathy, and autoimmune uveitis. Rapid progress 692 in personalized treatments has led to the exploration of exosome research in the context of ocular diseases, which holds potential for advancing drug delivery studies utilizing exosomes. This chapter emphasizes the importance of exosomes in the treatment of various ophthalmic ailments, followed by their challenges and future perspectives.